Immunotherapy and Companion Diagnostics: The Synergistic Partnership Defining Future Clinical Trials
Immunotherapy has emerged as one of the most transformative modalities in cancer treatment, offering durable responses in patients with previously incurable malignancies. However, unlike traditional chemotherapy, immunotherapy response rates are highly variable, making the selection of appropriate patients a complex task. This complexity has positioned companion diagnostics as a foundational...
0 Commentarios 0 Acciones 189 Views 0 Vista previa
MTSocial https://mtsocial.ir